Literature DB >> 17357509

The expression of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in psoriasis skin.

Xu'e Chen1, Zhijian Tan, Qing Yue, Houjun Liu, Zhixiang Liu, Jiawen Li.   

Abstract

In order to investigate the mRNA expression and function of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in the psoriatic lesion, no-lesion and normal human skin, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of IL-23 (p19/p40) and IL-12 (p35/p40). The results showed that the expression of IL-23p19 mRNA and p40 (IL-12/IL-23) mRNA were higher in psoriatic lesion than those of non-lesional skin and normal skin. The levels of IL-23p19 mRNA and p40 (IL-12/IL-23) mRNA were higher in psoriatic non-lesional skin than normal skin. However, no significant difference was found in the level of IL-12p35 mRNA among the psoriatic lesional skin, non-lesional skin and normal skin. It was suggested that IL-23 might be more important in the pathogenesis of psoriasis than IL-12.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17357509     DOI: 10.1007/s11596-006-0635-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

2.  Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death.

Authors:  M T Wiekowski; M W Leach; E W Evans; L Sullivan; S C Chen; G Vassileva; J F Bazan; D M Gorman; R A Kastelein; S Narula; S A Lira
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

3.  Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT.

Authors:  Shoichiro Yano; Mayumi Komine; Manabu Fujimoto; Hitoshi Okochi; Kunihiko Tamaki
Journal:  Biochem Biophys Res Commun       Date:  2003-02-21       Impact factor: 3.575

4.  Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris.

Authors:  Francesca Chamian; Michelle A Lowes; Shao-Lee Lin; Edmund Lee; Toyoko Kikuchi; Patricia Gilleaudeau; Mary Sullivan-Whalen; Irma Cardinale; Artemis Khatcherian; Inna Novitskaya; Knut M Wittkowski; James G Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

5.  Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23.

Authors:  G Piskin; U Tursen; R M R Sylva-Steenland; J D Bos; M B M Teunissen
Journal:  Exp Dermatol       Date:  2004-12       Impact factor: 3.960

6.  A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.

Authors:  Christi Parham; Madaline Chirica; Jacqueline Timans; Elena Vaisberg; Marilyn Travis; Jeanne Cheung; Stefan Pflanz; Rebecca Zhang; Komal P Singh; Felix Vega; Wayne To; Janet Wagner; Anne-Marie O'Farrell; Terrill McClanahan; Sandra Zurawski; Charles Hannum; Daniel Gorman; Donna M Rennick; Robert A Kastelein; Rene de Waal Malefyt; Kevin W Moore
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

8.  IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.

Authors:  Tamara Kopp; Petra Lenz; Concha Bello-Fernandez; Robert A Kastelein; Thomas S Kupper; Georg Stingl
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

9.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

Review 10.  Novel IL-12 family members shed light on the orchestration of Th1 responses.

Authors:  Frank Brombacher; Robert A Kastelein; Gottfried Alber
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

  10 in total
  3 in total

1.  Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.

Authors:  Nora Koutruba; Jason Emer; Mark Lebwohl
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

Review 2.  The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.

Authors:  A Egeberg; P Gisondi; J M Carrascosa; R B Warren; U Mrowietz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-15       Impact factor: 6.166

Review 3.  From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment.

Authors:  Silvia Vidal; Lluís Puig; José-Manuel Carrascosa-Carrillo; Álvaro González-Cantero; José-Carlos Ruiz-Carrascosa; Antonio-Manuel Velasco-Pastor
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.